Psychedelic Alpha, en intressant läcka/“insiderrykte” gällande bolaget AtaiBeckley inom sektorn. Den ursprungliga läckan till Bloomberg kom ju i mars och nu verkar det ta fart igen:
” Sources Say AtaiBeckley Deal Close to Completion
In Q1, rumours of a potential partnering deal concerning AtaiBeckley’s lead candidate, BPL-003 (intranasal 5-MeO-DMT for treatment-resistant depression) swirled, as we reported in March.
Since then, it’s been crickets; at least publicly. But people familiar with the matter told Psychedelic Alpha that news should come soon, with a potential announcement this month.
There are three kinds of offer on the table, the sources told us, including a full takeover of the company, codevelopment of BPL-003 alone, and a royalty investment deal. AtaiBeckley’s board is currently weighing these offers, they said.
The dealmaking process may have been buoyed by Definium’s positive market momentum. Indeed, at least one pharma player came to the table right after the LSD drug developer’s Phase 3 readout, we understand.”
Enligt min bedömning är Psychedelic Alpha en pålitlig och väl nätverkad informationskälla, och jag ser fram emot att se vad som kommer därifrån. Igår återförde jag de justerade medlen till ATAI från Compass direkt vid öppning…